Vaccine Adjuvants Market - Global Outlook and Forecast 2021-2027

March 2021 | 91 pages | ID: V2074F186580EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Vaccine Adjuvants in global, including the following market information:

Global Vaccine Adjuvants Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Vaccine Adjuvants Market Sales, 2016-2021, 2022-2027, (MT)

Global top five Vaccine Adjuvants companies in 2020 (%)

The global Vaccine Adjuvants market was valued at 784.1 million in 2020 and is projected to reach US$ 1138 million by 2027, at a CAGR of 9.8% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vaccine Adjuvants manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vaccine Adjuvants Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)

Global Vaccine Adjuvants Market Segment Percentages, By Type, 2020 (%)

• Oral
• Subcutaneous
• Intramuscular
• Others

Global Vaccine Adjuvants Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)

Global Vaccine Adjuvants Market Segment Percentages, By Application, 2020 (%)

• Human Vaccine Adjuvants
• Veterinary Vaccine Adjuvants

Global Vaccine Adjuvants Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (MT)

Global Vaccine Adjuvants Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vaccine Adjuvants revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Vaccine Adjuvants revenues share in global market, 2020 (%)

Key companies Vaccine Adjuvants sales in global market, 2016-2021 (Estimated), (MT)

Key companies Vaccine Adjuvants sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

• SEPPIC
• SDA BIO
• Brenntag Biosector
• SPI Pharma
• MVP Laboratories
• Tj Kaiwei
• Novavax
• Zhuoyue
• Aphios

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Vaccine Adjuvants Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Vaccine Adjuvants Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VACCINE ADJUVANTS OVERALL MARKET SIZE

2.1 Global Vaccine Adjuvants Market Size: 2021 VS 2027
2.2 Global Vaccine Adjuvants Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Vaccine Adjuvants Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Vaccine Adjuvants Players in Global Market
3.2 Top Global Vaccine Adjuvants Companies Ranked by Revenue
3.3 Global Vaccine Adjuvants Revenue by Companies
3.4 Global Vaccine Adjuvants Sales by Companies
3.5 Global Vaccine Adjuvants Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Vaccine Adjuvants Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Vaccine Adjuvants Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vaccine Adjuvants Players in Global Market
  3.8.1 List of Global Tier 1 Vaccine Adjuvants Companies
  3.8.2 List of Global Tier 2 and Tier 3 Vaccine Adjuvants Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Vaccine Adjuvants Market Size Markets, 2021 & 2027
  4.1.2 Oral
  4.1.3 Subcutaneous
  4.1.4 Intramuscular
  4.1.5 Others
4.2 By Type - Global Vaccine Adjuvants Revenue & Forecasts
  4.2.1 By Type - Global Vaccine Adjuvants Revenue, 2016-2021
  4.2.2 By Type - Global Vaccine Adjuvants Revenue, 2022-2027
  4.2.3 By Type - Global Vaccine Adjuvants Revenue Market Share, 2016-2027
4.3 By Type - Global Vaccine Adjuvants Sales & Forecasts
  4.3.1 By Type - Global Vaccine Adjuvants Sales, 2016-2021
  4.3.2 By Type - Global Vaccine Adjuvants Sales, 2022-2027
  4.3.3 By Type - Global Vaccine Adjuvants Sales Market Share, 2016-2027
4.4 By Type - Global Vaccine Adjuvants Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Vaccine Adjuvants Market Size, 2021 & 2027
  5.1.2 Human Vaccine Adjuvants
  5.1.3 Veterinary Vaccine Adjuvants
5.2 By Application - Global Vaccine Adjuvants Revenue & Forecasts
  5.2.1 By Application - Global Vaccine Adjuvants Revenue, 2016-2021
  5.2.2 By Application - Global Vaccine Adjuvants Revenue, 2022-2027
  5.2.3 By Application - Global Vaccine Adjuvants Revenue Market Share, 2016-2027
5.3 By Application - Global Vaccine Adjuvants Sales & Forecasts
  5.3.1 By Application - Global Vaccine Adjuvants Sales, 2016-2021
  5.3.2 By Application - Global Vaccine Adjuvants Sales, 2022-2027
  5.3.3 By Application - Global Vaccine Adjuvants Sales Market Share, 2016-2027
5.4 By Application - Global Vaccine Adjuvants Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Vaccine Adjuvants Market Size, 2021 & 2027
6.2 By Region - Global Vaccine Adjuvants Revenue & Forecasts
  6.2.1 By Region - Global Vaccine Adjuvants Revenue, 2016-2021
  6.2.2 By Region - Global Vaccine Adjuvants Revenue, 2022-2027
  6.2.3 By Region - Global Vaccine Adjuvants Revenue Market Share, 2016-2027
6.3 By Region - Global Vaccine Adjuvants Sales & Forecasts
  6.3.1 By Region - Global Vaccine Adjuvants Sales, 2016-2021
  6.3.2 By Region - Global Vaccine Adjuvants Sales, 2022-2027
  6.3.3 By Region - Global Vaccine Adjuvants Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Vaccine Adjuvants Revenue, 2016-2027
  6.4.2 By Country - North America Vaccine Adjuvants Sales, 2016-2027
  6.4.3 US Vaccine Adjuvants Market Size, 2016-2027
  6.4.4 Canada Vaccine Adjuvants Market Size, 2016-2027
  6.4.5 Mexico Vaccine Adjuvants Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Vaccine Adjuvants Revenue, 2016-2027
  6.5.2 By Country - Europe Vaccine Adjuvants Sales, 2016-2027
  6.5.3 Germany Vaccine Adjuvants Market Size, 2016-2027
  6.5.4 France Vaccine Adjuvants Market Size, 2016-2027
  6.5.5 U.K. Vaccine Adjuvants Market Size, 2016-2027
  6.5.6 Italy Vaccine Adjuvants Market Size, 2016-2027
  6.5.7 Russia Vaccine Adjuvants Market Size, 2016-2027
  6.5.8 Nordic Countries Vaccine Adjuvants Market Size, 2016-2027
  6.5.9 Benelux Vaccine Adjuvants Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Vaccine Adjuvants Revenue, 2016-2027
  6.6.2 By Region - Asia Vaccine Adjuvants Sales, 2016-2027
  6.6.3 China Vaccine Adjuvants Market Size, 2016-2027
  6.6.4 Japan Vaccine Adjuvants Market Size, 2016-2027
  6.6.5 South Korea Vaccine Adjuvants Market Size, 2016-2027
  6.6.6 Southeast Asia Vaccine Adjuvants Market Size, 2016-2027
  6.6.7 India Vaccine Adjuvants Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Vaccine Adjuvants Revenue, 2016-2027
  6.7.2 By Country - South America Vaccine Adjuvants Sales, 2016-2027
  6.7.3 Brazil Vaccine Adjuvants Market Size, 2016-2027
  6.7.4 Argentina Vaccine Adjuvants Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Vaccine Adjuvants Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Vaccine Adjuvants Sales, 2016-2027
  6.8.3 Turkey Vaccine Adjuvants Market Size, 2016-2027
  6.8.4 Israel Vaccine Adjuvants Market Size, 2016-2027
  6.8.5 Saudi Arabia Vaccine Adjuvants Market Size, 2016-2027
  6.8.6 UAE Vaccine Adjuvants Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 SEPPIC
  7.1.1 SEPPIC Corporate Summary
  7.1.2 SEPPIC Business Overview
  7.1.3 SEPPIC Vaccine Adjuvants Major Product Offerings
  7.1.4 SEPPIC Vaccine Adjuvants Sales and Revenue in Global (2016-2021)
  7.1.5 SEPPIC Key News
7.2 SDA BIO
  7.2.1 SDA BIO Corporate Summary
  7.2.2 SDA BIO Business Overview
  7.2.3 SDA BIO Vaccine Adjuvants Major Product Offerings
  7.2.4 SDA BIO Vaccine Adjuvants Sales and Revenue in Global (2016-2021)
  7.2.5 SDA BIO Key News
7.3 Brenntag Biosector
  7.3.1 Brenntag Biosector Corporate Summary
  7.3.2 Brenntag Biosector Business Overview
  7.3.3 Brenntag Biosector Vaccine Adjuvants Major Product Offerings
  7.3.4 Brenntag Biosector Vaccine Adjuvants Sales and Revenue in Global (2016-2021)
  7.3.5 Brenntag Biosector Key News
7.4 SPI Pharma
  7.4.1 SPI Pharma Corporate Summary
  7.4.2 SPI Pharma Business Overview
  7.4.3 SPI Pharma Vaccine Adjuvants Major Product Offerings
  7.4.4 SPI Pharma Vaccine Adjuvants Sales and Revenue in Global (2016-2021)
  7.4.5 SPI Pharma Key News
7.5 MVP Laboratories
  7.5.1 MVP Laboratories Corporate Summary
  7.5.2 MVP Laboratories Business Overview
  7.5.3 MVP Laboratories Vaccine Adjuvants Major Product Offerings
  7.5.4 MVP Laboratories Vaccine Adjuvants Sales and Revenue in Global (2016-2021)
  7.5.5 MVP Laboratories Key News
7.6 Tj Kaiwei
  7.6.1 Tj Kaiwei Corporate Summary
  7.6.2 Tj Kaiwei Business Overview
  7.6.3 Tj Kaiwei Vaccine Adjuvants Major Product Offerings
  7.6.4 Tj Kaiwei Vaccine Adjuvants Sales and Revenue in Global (2016-2021)
  7.6.5 Tj Kaiwei Key News
7.7 Novavax
  7.7.1 Novavax Corporate Summary
  7.7.2 Novavax Business Overview
  7.7.3 Novavax Vaccine Adjuvants Major Product Offerings
  7.4.4 Novavax Vaccine Adjuvants Sales and Revenue in Global (2016-2021)
  7.7.5 Novavax Key News
7.8 Zhuoyue
  7.8.1 Zhuoyue Corporate Summary
  7.8.2 Zhuoyue Business Overview
  7.8.3 Zhuoyue Vaccine Adjuvants Major Product Offerings
  7.8.4 Zhuoyue Vaccine Adjuvants Sales and Revenue in Global (2016-2021)
  7.8.5 Zhuoyue Key News
7.9 Aphios
  7.9.1 Aphios Corporate Summary
  7.9.2 Aphios Business Overview
  7.9.3 Aphios Vaccine Adjuvants Major Product Offerings
  7.9.4 Aphios Vaccine Adjuvants Sales and Revenue in Global (2016-2021)
  7.9.5 Aphios Key News

8 GLOBAL VACCINE ADJUVANTS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Vaccine Adjuvants Production Capacity, 2016-2027
8.2 Vaccine Adjuvants Production Capacity of Key Manufacturers in Global Market
8.3 Global Vaccine Adjuvants Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 VACCINE ADJUVANTS SUPPLY CHAIN ANALYSIS

10.1 Vaccine Adjuvants Industry Value Chain
10.2 Vaccine Adjuvants Upstream Market
10.3 Vaccine Adjuvants Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Vaccine Adjuvants Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Vaccine Adjuvants in Global Market
Table 2. Top Vaccine Adjuvants Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Vaccine Adjuvants Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Vaccine Adjuvants Revenue Share by Companies, 2016-2021
Table 5. Global Vaccine Adjuvants Sales by Companies, (MT), 2016-2021
Table 6. Global Vaccine Adjuvants Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Vaccine Adjuvants Price (2016-2021) & (USD/Kg)
Table 8. Global Manufacturers Vaccine Adjuvants Product Type
Table 9. List of Global Tier 1 Vaccine Adjuvants Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaccine Adjuvants Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Vaccine Adjuvants Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Vaccine Adjuvants Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Vaccine Adjuvants Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Vaccine Adjuvants Sales (MT), 2016-2021
Table 15. By Type - Global Vaccine Adjuvants Sales (MT), 2022-2027
Table 16. By Application – Global Vaccine Adjuvants Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Vaccine Adjuvants Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Vaccine Adjuvants Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Vaccine Adjuvants Sales (MT), 2016-2021
Table 20. By Application - Global Vaccine Adjuvants Sales (MT), 2022-2027
Table 21. By Region – Global Vaccine Adjuvants Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Vaccine Adjuvants Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Vaccine Adjuvants Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Vaccine Adjuvants Sales (MT), 2016-2021
Table 25. By Region - Global Vaccine Adjuvants Sales (MT), 2022-2027
Table 26. By Country - North America Vaccine Adjuvants Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Vaccine Adjuvants Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Vaccine Adjuvants Sales, (MT), 2016-2021
Table 29. By Country - North America Vaccine Adjuvants Sales, (MT), 2022-2027
Table 30. By Country - Europe Vaccine Adjuvants Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Vaccine Adjuvants Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Vaccine Adjuvants Sales, (MT), 2016-2021
Table 33. By Country - Europe Vaccine Adjuvants Sales, (MT), 2022-2027
Table 34. By Region - Asia Vaccine Adjuvants Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Vaccine Adjuvants Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Vaccine Adjuvants Sales, (MT), 2016-2021
Table 37. By Region - Asia Vaccine Adjuvants Sales, (MT), 2022-2027
Table 38. By Country - South America Vaccine Adjuvants Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Vaccine Adjuvants Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Vaccine Adjuvants Sales, (MT), 2016-2021
Table 41. By Country - South America Vaccine Adjuvants Sales, (MT), 2022-2027
Table 42. By Country - Middle East & Africa Vaccine Adjuvants Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Vaccine Adjuvants Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Vaccine Adjuvants Sales, (MT), 2016-2021
Table 45. By Country - Middle East & Africa Vaccine Adjuvants Sales, (MT), 2022-2027
Table 46. SEPPIC Corporate Summary
Table 47. SEPPIC Vaccine Adjuvants Product Offerings
Table 48. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 49. SDA BIO Corporate Summary
Table 50. SDA BIO Vaccine Adjuvants Product Offerings
Table 51. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 52. Brenntag Biosector Corporate Summary
Table 53. Brenntag Biosector Vaccine Adjuvants Product Offerings
Table 54. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 55. SPI Pharma Corporate Summary
Table 56. SPI Pharma Vaccine Adjuvants Product Offerings
Table 57. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 58. MVP Laboratories Corporate Summary
Table 59. MVP Laboratories Vaccine Adjuvants Product Offerings
Table 60. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 61. Tj Kaiwei Corporate Summary
Table 62. Tj Kaiwei Vaccine Adjuvants Product Offerings
Table 63. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 64. Novavax Corporate Summary
Table 65. Novavax Vaccine Adjuvants Product Offerings
Table 66. Novavax Vaccine Adjuvants Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 67. Zhuoyue Corporate Summary
Table 68. Zhuoyue Vaccine Adjuvants Product Offerings
Table 69. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 70. Aphios Corporate Summary
Table 71. Aphios Vaccine Adjuvants Product Offerings
Table 72. Aphios Vaccine Adjuvants Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 73. Vaccine Adjuvants Production Capacity (MT) of Key Manufacturers in Global Market, 2019-2021 (MT)
Table 74. Global Vaccine Adjuvants Capacity Market Share of Key Manufacturers, 2019-2021
Table 75. Global Vaccine Adjuvants Production by Region, 2016-2021 (MT)
Table 76. Global Vaccine Adjuvants Production by Region, 2022-2027 (MT)
Table 77. Vaccine Adjuvants Market Opportunities & Trends in Global Market
Table 78. Vaccine Adjuvants Market Drivers in Global Market
Table 79. Vaccine Adjuvants Market Restraints in Global Market
Table 80. Vaccine Adjuvants Raw Materials
Table 81. Vaccine Adjuvants Raw Materials Suppliers in Global Market
Table 82. Typical Vaccine Adjuvants Downstream
Table 83. Vaccine Adjuvants Downstream Clients in Global Market
Table 84. Vaccine Adjuvants Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Vaccine Adjuvants Segment by Type
Figure 2. Vaccine Adjuvants Segment by Application
Figure 3. Global Vaccine Adjuvants Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Vaccine Adjuvants Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Vaccine Adjuvants Revenue, 2016-2027 (US$, Mn)
Figure 7. Vaccine Adjuvants Sales in Global Market: 2016-2027 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Vaccine Adjuvants Revenue in 2020
Figure 9. By Type - Global Vaccine Adjuvants Sales Market Share, 2016-2027
Figure 10. By Type - Global Vaccine Adjuvants Revenue Market Share, 2016-2027
Figure 11. By Type - Global Vaccine Adjuvants Price (USD/Kg), 2016-2027
Figure 12. By Application - Global Vaccine Adjuvants Sales Market Share, 2016-2027
Figure 13. By Application - Global Vaccine Adjuvants Revenue Market Share, 2016-2027
Figure 14. By Application - Global Vaccine Adjuvants Price (USD/Kg), 2016-2027
Figure 15. By Region - Global Vaccine Adjuvants Sales Market Share, 2016-2027
Figure 16. By Region - Global Vaccine Adjuvants Revenue Market Share, 2016-2027
Figure 17. By Country - North America Vaccine Adjuvants Revenue Market Share, 2016-2027
Figure 18. By Country - North America Vaccine Adjuvants Sales Market Share, 2016-2027
Figure 19. US Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Vaccine Adjuvants Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Vaccine Adjuvants Sales Market Share, 2016-2027
Figure 24. Germany Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 25. France Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Vaccine Adjuvants Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Vaccine Adjuvants Sales Market Share, 2016-2027
Figure 33. China Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 37. India Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Vaccine Adjuvants Revenue Market Share, 2016-2027
Figure 39. By Country - South America Vaccine Adjuvants Sales Market Share, 2016-2027
Figure 40. Brazil Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Vaccine Adjuvants Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Vaccine Adjuvants Sales Market Share, 2016-2027
Figure 44. Turkey Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Vaccine Adjuvants Revenue, (US$, Mn), 2016-2027
Figure 48. Global Vaccine Adjuvants Production Capacity (MT), 2016-2027
Figure 49. The Percentage of Production Vaccine Adjuvants by Region, 2020 VS 2027
Figure 50. Vaccine Adjuvants Industry Value Chain
Figure 51. Marketing Channels